On Mar 2, 2022 Vesalius Therapeutics closed a Series A round and raised $75,000,000 from Flagship Pioneering, featuring lead investors Flagship Pioneering.

About the company: Vesalius Therapeutics is located at United States, North America.
“At Vesalius Therapeutics, we believe it is time to re-think and redefine how we treat common illnesses. Founded by Flagship Pioneering , we are building a…”

Company website: http://www.vesaliustx.com